D12-Senior Study Director Large Molecule/Toxicolog
上海睿智化学研究有限公司
- 公司规模:1000-5000人
- 公司性质:外资(欧美)
- 公司行业:制药/生物工程
职位信息
- 发布日期:2016-09-25
- 工作地点:上海
- 招聘人数:1人
- 职位月薪:10000+ /月
- 职位类别:生物工程/生物制药
职位描述
职位描述:
Job Description
- To propose preclinical strategies, design and coordinate appropriate preclinical studies, primarily PK, PKPD, BioAnalytical, and Tox to support preclinical development of drug candidates mainly biologics to successfully IND filing
- To implement studies in preparing protocols, monitoring study progress, analyzing data and writing reports and regulatory documentation and reporting to the client or integrate project team.
- To conduct extensive reference search and information collection of recently science advancement and report/present to the manager and project team.
- To coordinate cross-functional effort (Discovery, Pharmacology, CMC, Registration and business partners) in planning budgets, timelines and resource allocations
- To participate meeting and teleconference with global clients/team members during after work hours
- To thrive in a fast paced science-driven environment and collaborate with people with diverse backgrounds. He/she might be expected to contribute to the scientific direction of this group, mentoring the staff, and nurturing technological innovation.
- Might supervise and team build team, depending upon qualification, a group of SDs
Requirement
- A MD, MS or Ph.D in toxicology, biochemistry, biology, or life-science related discipline is required.
- Knowledgeable in fundamental toxicology, large molecule discovery and development
- Prior experience in animal study and/or biology assay and well understanding of in vivo system, bioanalytical assay (LBA), PK is highly expected
- Excellent interpersonal and communication in both Chinese and English
- Prior experience in preclinical development in life science industry is a big plus
- Strong collaborative skills and ability to work in a team environment expected
举报
分享
Job Description
- To propose preclinical strategies, design and coordinate appropriate preclinical studies, primarily PK, PKPD, BioAnalytical, and Tox to support preclinical development of drug candidates mainly biologics to successfully IND filing
- To implement studies in preparing protocols, monitoring study progress, analyzing data and writing reports and regulatory documentation and reporting to the client or integrate project team.
- To conduct extensive reference search and information collection of recently science advancement and report/present to the manager and project team.
- To coordinate cross-functional effort (Discovery, Pharmacology, CMC, Registration and business partners) in planning budgets, timelines and resource allocations
- To participate meeting and teleconference with global clients/team members during after work hours
- To thrive in a fast paced science-driven environment and collaborate with people with diverse backgrounds. He/she might be expected to contribute to the scientific direction of this group, mentoring the staff, and nurturing technological innovation.
- Might supervise and team build team, depending upon qualification, a group of SDs
Requirement
- A MD, MS or Ph.D in toxicology, biochemistry, biology, or life-science related discipline is required.
- Knowledgeable in fundamental toxicology, large molecule discovery and development
- Prior experience in animal study and/or biology assay and well understanding of in vivo system, bioanalytical assay (LBA), PK is highly expected
- Excellent interpersonal and communication in both Chinese and English
- Prior experience in preclinical development in life science industry is a big plus
- Strong collaborative skills and ability to work in a team environment expected
职能类别: 生物工程/生物制药
公司介绍
上海睿智化学研究有限公司成立于2002年,是一家世界领先的科研外包服务机构(CRO),秉承着创新驱动、客户至上的服务理念,致力于为全球制药公司和生物技术公司提供全面且高品质的新药研发服务。
公司业务涵盖了抗体早期研发、小分子早期研发、药理药效、药代药动及早期毒理、生物药CMC、化药CMC、临床样品生产等新药研发各环节,为客户提供整合一体化的新药研发外包服务,已经服务过的国内外制药企业和生物医药技术公司1000余家,其中包括全球排名前20位的医药和生物技术企业。
公司在全球设立了6个办事处,专职研发人员2000人,海归科学家150人,拥有大规模最先进的科研、办公设施、实验动物设施、cGMP级别的公斤级实验室以及医药中间体生产设施。公司通过坐落于张江、奉贤、启东、成都和南旧金山五个重要研发基地持续不断为来自全球范围内客户长期提供优质的服务。
公司业务涵盖了抗体早期研发、小分子早期研发、药理药效、药代药动及早期毒理、生物药CMC、化药CMC、临床样品生产等新药研发各环节,为客户提供整合一体化的新药研发外包服务,已经服务过的国内外制药企业和生物医药技术公司1000余家,其中包括全球排名前20位的医药和生物技术企业。
公司在全球设立了6个办事处,专职研发人员2000人,海归科学家150人,拥有大规模最先进的科研、办公设施、实验动物设施、cGMP级别的公斤级实验室以及医药中间体生产设施。公司通过坐落于张江、奉贤、启东、成都和南旧金山五个重要研发基地持续不断为来自全球范围内客户长期提供优质的服务。
联系方式
- Email:sygu@chempartner.cn
- 公司地址:金科路2829号金科中心A栋